4//SEC Filing
Wheadon David E. 4
Accession 0000950170-23-029416
CIK 0001771917other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:18 PM ET
Size
6.8 KB
Accession
0000950170-23-029416
Insider Transaction Report
Form 4
Wheadon David E.
Director
Transactions
- Award
Common Stock
2023-06-20+990→ 990 total - Award
Option (right to buy)
2023-06-20+1,904→ 1,904 totalExercise: $237.70Exp: 2033-06-19→ Common Stock (1,904 underlying)
Footnotes (2)
- [F1]Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates.
- [F2]This option shall vest in full upon the earlier of (i) June 20, 2024, and (ii) the 2024 annual meeting of the Issuer's stockholders, subject to continued service through such dates.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001789507
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:18 PM ET
- Size
- 6.8 KB